The HFSA Heart Failure Seminar: Focus on Novel and Emerging Myocarditides: Recognition and Management, is part of the HFSA’s ongoing Focus On seminar series which brings together healthcare providers (HCPs). Featuring expert presentations on critical topics in epidemiology, recognition, and management, this seminar brings together leading experts to delve into the latest advancements and practical insights essential for healthcare professionals at the forefront of cardiac care.
This activity is intended for cardiologists, interventional cardiologists, primary care physicians, cardiac surgeons, internists, nurse practitioners, physician assistants, nurses, pharmacists, and other health care providers who care for patients with heart failure.
At the conclusion of this activity, learners will be better able to:
- Recognize the changes in myocarditis epidemiology over the past century that impact the clinical spectrum of disease.
- Describe the clinical, imaging and histologic predictors of death, ventricular arrhythmia and heart transplantation in acute myocarditis
- Differentiate the treatment of lymphocytic myocarditis from giant cell myocarditis, immune checkpoint inhibitor myocarditis, and cardiac sarcoidosis
Program Agenda
All sessions are listed in Eastern Standard Time.
Welcome Remarks
Epidemiology of Emerging Myocardities (Long COVID, HIV, and Beyond)
Leslie Cooper, MD, FHFSA
Recognition and Diagnosis (Novel Biomarkers and Imaging)
Wilson Tang, MD, FHFSA
Management and Treatment
Craig Beavers, PharmD
Panel Discussion